Andembry (garadacimab-gxii) is a prescription drug that’s used to help prevent attacks of hereditary angioedema (HAE) in adults and certain children. Andembry comes as a liquid solution that’s given ...
The approval is based on the results of the international pivotal Phase 3 VANGUARD trial, which included HAE patients from Japan CSL is dedicated to improving the lives of those with HAE – a community ...
ANDEMBRY® is a first-in-class monoclonal antibody treatment that inhibits activated Factor XII (FXIIa), the initiating factor in the HAE pathway, and offers the first pre-filled pen presentation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results